ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
CP006185 |
|
21187-98-4 |
Gliclazide - 99% |
0 | C15H21N3O3S | |
CP005235 |
|
33342-05-1 |
Gliquidone - 98.0~102.0% |
0 | C27H33N3O6S | |
CP000336 |
|
102-76-1 |
Triacetin - 99% |
0 | C9H14O6 | |
CP008106 |
|
29608-49-9 |
N,N'-diallyl-6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-1,3,5-triazine-2,4-diamine dimethanesulphonate - 98% |
0 | C26H29N7F2.2[CH4O3S] | |
CP003105 |
|
872728-81-9 |
Hexyl 2-(4-(((5-((3-ethoxy-3-oxopropyl)(pyridin-2-yl)carbamoyl)-1-methyl-1H-benzo[d]imidazol-2-yl)methyl)amino)benzylidene)hydrazinecarboxylate methanesulfonate - 98.0% |
0 | C34H41N7O5.CH4O3S | |
CP005438 |
|
7585-39-9 |
beta-cyclodextrin - 98% |
0 | C42H70O35 | |
CP008134 |
|
72-14-0 |
Sulfathiazole - 99% |
0 | C9H9N3O2S2 | |
CP004603 |
|
65666-07-1 |
silymarin - 98% |
0 | C25H22O10 | |
CP006248 |
|
4563-84-2 |
Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, sodium salt (1:1) - 99% |
0 | C10H11N3O3S.NA | |
CP006227 |
|
418541-41-0 |
(2Z)-3-methyl-4-oxo-4-(1H-pyrrol-2-yl)but-2-enoic acid - 98% |
0 | C9H9NO3 | |
CP005526 |
|
554-68-7 |
Ethanamine,N,N-diethyl-,hydrochloride - 99% |
0 | C6H15N.HCL;C6H16CLN | |
CP001384 |
|
31284-96-5 |
Potassium ((2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl)sulfamate - 98.0-102.0% |
0 | C6H12NO8S-.K | |
CP000058 |
|
66-84-2 |
D-Glucosamine hydrochloride - 98.0 ~ 102.0% |
0 | C6H14CLNO5 | |
CP003067 |
|
161973-10-0 |
Esomeprazole magnesium - 97% |
0 | 2(C17H18N3O3S)2.MG | |
CP006202 |
|
1122-91-4 |
4-Bromobenzaldehyde - 99% |
0 | C7H5BrO | |
CP001825 |
|
17201-43-3 |
4-Cyanobenzyl bromide - 98% |
0 | C8H6NBR | |
CP004191 |
|
99-94-5 |
4-Methylbenzoic acid - 99% |
0 | C8H8O2 | |
CP003866 |
|
117428-22-5 |
Picoxystrobin - ≥95% |
0 | C18H16F3NO4 | |
CP006737 |
|
499-40-1 |
ISOMALTOSE - 90% |
0 | C12H22O11 | |
CP002337 |
|
482-89-3 |
Indigo - 99% |
0 | C16H10N2O2 | |